OTC miconazole promotion by Florida PruCare decreased Rx cream use by 24% in first year.
This article was originally published in The Tan Sheet
Executive Summary
OTC MICONAZOLE PROMOTION BY FLORIDA PRUCARE LED TO 24% FEWER PRESCRIPTIONS for Terazol, Ortho's Rx terconazole cream for vaginal yeast infections, during the first year, Integrated Pharmacy Solutions Divisional Pharmacy Director William Mazanec reported at a Jan. 24-26 managed care conference in Orlando, Fla. Discussing the results of the fledgling OTC support program initiated by the managed care organization in mid-1993, Mazanec also noted that the decrease in Terazol prescriptions "has sustained itself" into the second year.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning